Key Metrics
SJR 

Q4Cultural Studies

Recommended pre-submission checks
Powered by 

CUADERNOS HISPANOAMERICANOS Journal Specifications
Indexed in the following public directories
Web of Science
| Overview | |
| Publisher | AGENCIA ESPANOLA COOPERACION INT DESARROLO-AECID |
| Language | Spanish |
| Frequency | Monthly |
| General Details | |
| Language | Spanish |
| Frequency | Monthly |
| Publication Start Year | 1948 |
View less
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers in CUADERNOS HISPANOAMERICANOS
Neuroimmune treatment of advanced solid tumors: 3-year survival after angiotensin 1-7, pineal indoles, and cannabinoids.
- 4 Aug 2026
- Neoplasma
CRISPR/Cas9-edited organoids as a platform for tailored research of colorectal cancer.
- 4 Aug 2026
- Neoplasma
SMAP1 promotes hepatoblastoma cell proliferation by modulating the C-Kit-activated ERK/MAPK pathway.
- 28 Jul 2026
- Neoplasma
A splice odyssey: periostin's journey through the sea of crabs.
- 28 Jul 2026
- Neoplasma
Real-world clinical outcomes of newly diagnosed AML unfit for intensive chemotherapy treated with venetoclax and azacitidine: does it depend on the number of days of venetoclax administration?
- 22 Jul 2026
- Neoplasma
Baseline circulating tumor plasma cells are associated with progression-free survival in newly diagnosed multiple myeloma: a single-center real-world NGF study.
- 22 Jul 2026
- Neoplasma
Neuroimmune treatment of advanced solid tumors: 3-year survival after angiotensin 1-7, pineal indoles, and cannabinoids.
- 4 Aug 2026
- Neoplasma
CRISPR/Cas9-edited organoids as a platform for tailored research of colorectal cancer.
- 4 Aug 2026
- Neoplasma
SMAP1 promotes hepatoblastoma cell proliferation by modulating the C-Kit-activated ERK/MAPK pathway.
- 28 Jul 2026
- Neoplasma
A splice odyssey: periostin's journey through the sea of crabs.
- 28 Jul 2026
- Neoplasma
Real-world clinical outcomes of newly diagnosed AML unfit for intensive chemotherapy treated with venetoclax and azacitidine: does it depend on the number of days of venetoclax administration?
- 22 Jul 2026
- Neoplasma
Baseline circulating tumor plasma cells are associated with progression-free survival in newly diagnosed multiple myeloma: a single-center real-world NGF study.
- 22 Jul 2026
- Neoplasma